J 17 (Lamivudine 300 mg)
Pill with imprint J 17 is White, Capsule-shape and has been identified as Lamivudine 300 mg. It is supplied by Camber Pharmaceuticals, Inc.
Lamivudine is used in the treatment of hiv infection; hepatitis b; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for J 17
Lamivudine
- Imprint
- J 17
- Strength
- 300 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Camber Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 68554-5054
Related images for "J 17"
More about lamivudine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (5)
- Drug images
- Pricing & coupons
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.